SCAND3
gene geneOn this page
Also known as ZFP38-LKIAA1925FLJ31087Buster4FAM200D
Summary
SCAND3 (SCAN domain containing 3, HGNC:13851) is a protein-coding gene on chromosome 6p22.1, encoding SCAN domain-containing protein 3 (Q6R2W3).
Predicted to enable nucleic acid binding activity. Involved in positive regulation of cell cycle and positive regulation of epithelial cell proliferation. Located in cytoplasm.
Source: NCBI Gene 114821 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 30 (top 4% of genes corpus-wide)
- Clinical variants (ClinVar): 84 total
- GTEx eGene: eQTL in 13 tissues, sQTL in 1 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 0.59 (moderately constrained)
- MANE Select transcript:
NM_052923 - Notable: 84 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13851 |
| Approved symbol | SCAND3 |
| Name | SCAN domain containing 3 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZFP38-L, KIAA1925, FLJ31087, Buster4, FAM200D |
| Ensembl gene | ENSG00000232040 |
| Ensembl biotype | protein_coding |
| OMIM | 615254 |
| Entrez | 114821 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
MANE Select: ENST00000452236
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 1, TSL 3: 1, TSL 4: 1
ENST00000452236, ENST00000524745, ENST00000526291, ENST00000530247, ENST00000646382, ENST00000927696, ENST00000983442, ENST00001141618
RefSeq mRNA: 2 — MANE Select: NM_052923
NM_001329616, NM_052923
CCDS: CCDS34355, CCDS87376
Canonical transcript exons
ENST00000452236 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002439661 | 28574644 | 28576136 |
| ENSE00002480261 | 28586298 | 28587298 |
| ENSE00003522808 | 28579272 | 28579419 |
| ENSE00003821209 | 28570535 | 28573827 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 81.69.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1797 / max 34.4213, expressed in 783 samples.
Highest expression (Bgee): primordial germ cell in gonad, testis, secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis, ganglionic eminence.
Genetic regulation across tissues (GTEx eQTL / sQTL)
SCAND3 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 13 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
14 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Testis | eqtl | 1.4e-13 | +0.29 | 6:28557488:A:G |
| Artery Aorta | eqtl | 2.3e-07 | -0.35 | 6:28803421:T:C |
| Artery Tibial | eqtl | 2.4e-06 | -0.23 | 6:28554918:A:G |
| Pancreas | eqtl | 5.4e-04 | -0.36 | 6:27820212:G:A |
| Nerve Tibial | eqtl | 1.3e-03 | +0.24 | 6:29431161:T:C |
| Colon Transverse | eqtl | 5.4e-03 | -0.51 | 6:28347433:C:T |
| Esophagus Muscularis | eqtl | 1.6e-02 | +0.17 | 6:28674180:A:G |
| Thyroid | eqtl | 1.8e-02 | +0.19 | 6:28905384:A:C |
| Esophagus Mucosa | eqtl | 1.8e-02 | -0.16 | 6:28689413:G:A |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.2e-02 | -0.29 | 6:27691828:G:T |
| Testis | sqtl | 2.6e-02 | -0.36 | 6:27891059:T:C |
| Adipose Subcutaneous | eqtl | 2.8e-02 | -0.28 | 6:28194273:C:G |
| Brain Hippocampus | eqtl | 2.9e-02 | +0.26 | 6:29565804:AATAG:A |
| Minor Salivary Gland | eqtl | 3.3e-02 | +0.49 | 6:28826496:G:C |
FANTOM5 promoters
6 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72426 | 1.8098 | 730 |
| 72429 | 0.1276 | 42 |
| 72428 | 0.0868 | 35 |
| 72427 | 0.0761 | 35 |
| 72425 | 0.0568 | 21 |
| 72430 | 0.0226 | 14 |
Top tissues by expression
showing 100 of 250 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.69 | gold quality |
| left testis | UBERON:0004533 | 80.00 | gold quality |
| testis | UBERON:0000473 | 79.93 | gold quality |
| right testis | UBERON:0004534 | 79.39 | gold quality |
| secondary oocyte | CL:0000655 | 79.28 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.98 | gold quality |
| corpus epididymis | UBERON:0004359 | 74.96 | gold quality |
| cortical plate | UBERON:0005343 | 74.86 | gold quality |
| ventricular zone | UBERON:0003053 | 73.92 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.48 | gold quality |
| oocyte | CL:0000023 | 73.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.75 | gold quality |
| sperm | CL:0000019 | 70.42 | gold quality |
| sural nerve | UBERON:0015488 | 70.32 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 67.67 | gold quality |
| cerebellar cortex | UBERON:0002129 | 67.56 | gold quality |
| cerebellum | UBERON:0002037 | 66.99 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 66.90 | gold quality |
| seminal vesicle | UBERON:0000998 | 65.56 | gold quality |
| caput epididymis | UBERON:0004358 | 64.22 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.97 | gold quality |
| rectum | UBERON:0001052 | 62.85 | gold quality |
| pancreas | UBERON:0001264 | 62.75 | gold quality |
| tibialis anterior | UBERON:0001385 | 61.86 | silver quality |
| right lobe of liver | UBERON:0001114 | 61.79 | gold quality |
| ileal mucosa | UBERON:0000331 | 61.43 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 61.29 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 60.63 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.59 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.45 | gold quality |
| metanephros | UBERON:0000081 | 60.35 | gold quality |
| body of pancreas | UBERON:0001150 | 60.23 | gold quality |
| oviduct epithelium | UBERON:0004804 | 59.81 | silver quality |
| pituitary gland | UBERON:0000007 | 59.80 | gold quality |
| frontal cortex | UBERON:0001870 | 59.41 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 59.28 | gold quality |
| adenohypophysis | UBERON:0002196 | 59.27 | gold quality |
| placenta | UBERON:0001987 | 59.18 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 59.16 | gold quality |
| prostate gland | UBERON:0002367 | 59.14 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 58.95 | gold quality |
| ovary | UBERON:0000992 | 58.79 | gold quality |
| neocortex | UBERON:0001950 | 58.77 | gold quality |
| thyroid gland | UBERON:0002046 | 58.75 | gold quality |
| left adrenal gland | UBERON:0001234 | 58.70 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 58.59 | gold quality |
| right frontal lobe | UBERON:0002810 | 58.58 | gold quality |
| adult organism | UBERON:0007023 | 58.58 | gold quality |
| fallopian tube | UBERON:0003889 | 58.48 | gold quality |
| cauda epididymis | UBERON:0004360 | 58.48 | gold quality |
| endothelial cell | CL:0000115 | 58.42 | gold quality |
| adrenal gland | UBERON:0002369 | 58.42 | gold quality |
| left ovary | UBERON:0002119 | 58.04 | gold quality |
| liver | UBERON:0002107 | 57.39 | gold quality |
| right uterine tube | UBERON:0001302 | 57.28 | gold quality |
| pancreatic ductal cell | CL:0002079 | 57.22 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 57.17 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.89 | gold quality |
| adrenal cortex | UBERON:0001235 | 56.66 | gold quality |
| right ovary | UBERON:0002118 | 56.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.30 | gold quality |
| body of uterus | UBERON:0009853 | 56.27 | gold quality |
| hypothalamus | UBERON:0001898 | 56.18 | gold quality |
| cerebral cortex | UBERON:0000956 | 55.99 | gold quality |
| brain | UBERON:0000955 | 55.96 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 55.90 | gold quality |
| cortex of kidney | UBERON:0001225 | 55.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 55.50 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 55.26 | gold quality |
| forebrain | UBERON:0001890 | 54.95 | gold quality |
| kidney | UBERON:0002113 | 54.86 | gold quality |
| endocervix | UBERON:0000458 | 54.63 | gold quality |
| endometrium | UBERON:0001295 | 54.50 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| ectocervix | UBERON:0012249 | 54.34 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.31 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| female reproductive system | UBERON:0000474 | 54.20 | gold quality |
| tibia | UBERON:0000979 | 54.12 | silver quality |
| caudate nucleus | UBERON:0001873 | 54.09 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| deltoid | UBERON:0001476 | 53.58 | gold quality |
| left uterine tube | UBERON:0001303 | 53.56 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| bronchial epithelial cell | CL:0002328 | 53.50 | silver quality |
| colonic epithelium | UBERON:0000397 | 53.46 | gold quality |
| uterine cervix | UBERON:0000002 | 53.43 | gold quality |
| uterus | UBERON:0000995 | 53.38 | gold quality |
| bronchus | UBERON:0002185 | 52.88 | silver quality |
| gall bladder | UBERON:0002110 | 52.72 | gold quality |
| vermiform appendix | UBERON:0001154 | 52.40 | gold quality |
| minor salivary gland | UBERON:0001830 | 51.97 | gold quality |
| bone marrow cell | CL:0002092 | 51.90 | gold quality |
| heart left ventricle | UBERON:0002084 | 51.79 | gold quality |
| cardiac ventricle | UBERON:0002082 | 51.39 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 51.25 | gold quality |
| heart | UBERON:0000948 | 51.16 | gold quality |
| putamen | UBERON:0001874 | 50.62 | gold quality |
| lymph node | UBERON:0000029 | 50.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.34 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 73 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Testis | tissue | 8.1 |
| Caudate putamen | tissue | 5.1 |
| Frontal cortex | tissue | 4.4 |
| Postcentral gyrus | tissue | 3.4 |
| Epididymis | tissue | 2.9 |
| Cerebellum | tissue | 2.7 |
| Locus coeruleus | tissue | 2.5 |
| Hippocampal formation | tissue | 2.4 |
| Nucleus accumbens | tissue | 2.3 |
| Olfactory bulb | tissue | 2.3 |
| Hypothalamus | tissue | 2.2 |
| Hippocampus | tissue | 2.1 |
| Periaqueductal gray | tissue | 2.1 |
| Midbrain | tissue | 1.9 |
| Thalamus | tissue | 1.9 |
| Septum | tissue | 1.9 |
| Cerebral cortex | tissue | 1.8 |
| Pons | tissue | 1.8 |
| Motor cortex | tissue | 1.8 |
| Prefrontal cortex | tissue | 1.7 |
| Seminal vesicle | tissue | 1.7 |
| Basal ganglia | tissue | 1.7 |
| Amygdala | tissue | 1.7 |
| Entorhinal cortex | tissue | 1.7 |
| Putamen | tissue | 1.6 |
| Choroid plexus | tissue | 1.6 |
| Substantia nigra | tissue | 1.6 |
| Thyroid gland | tissue | 1.6 |
| Spinal cord | tissue | 1.6 |
| Corpus callosum | tissue | 1.6 |
| Ventral forebrain | tissue | 1.6 |
| Retrosplenial cortex | tissue | 1.6 |
| Temporal cortex | tissue | 1.6 |
| Medulla oblongata | tissue | 1.5 |
| Superior colliculi | tissue | 1.5 |
| Retrosplenial and cingulate cortex | tissue | 1.5 |
| Somatosensory cortex | tissue | 1.5 |
| Occipital cortex | tissue | 1.5 |
| Insular cortex | tissue | 1.5 |
| Retina | tissue | 1.4 |
| Prostate | tissue | 1.3 |
| Ovary | tissue | 1.1 |
| Liver | tissue | 1.1 |
| Fallopian tube | tissue | 1.1 |
| Parathyroid gland | tissue | 0.9 |
| Cervix | tissue | 0.8 |
| Breast | tissue | 0.8 |
| Kidney | tissue | 0.8 |
| Salivary gland | tissue | 0.7 |
| Placenta | tissue | 0.6 |
| Pituitary gland | tissue | 0.5 |
| Rectum | tissue | 0.5 |
| Endometrium 1 | tissue | 0.5 |
| Pancreas | tissue | 0.4 |
| Lung | tissue | 0.4 |
| Adrenal gland | tissue | 0.4 |
| Thymus | tissue | 0.4 |
| Stomach 1 | tissue | 0.3 |
| Smooth muscle | tissue | 0.3 |
| Colon | tissue | 0.3 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Cerebellar cortex (5.0), Flocculonodular lobe (4.6), Vermis (4.6), Stria terminalis, bed nucleus (3.4), Transversal temporal gyrus, anterior (3.2).
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2542.1 | SCAND3 | BED zinc finger factors |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
Targeting SCAND3 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
15 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-1-5P | 98.70 | 68.66 | 1017 |
| HSA-MIR-4305 | 97.94 | 68.63 | 533 |
| HSA-MIR-1295B-3P | 96.68 | 66.11 | 276 |
| HSA-MIR-4524B-3P | 95.52 | 64.12 | 964 |
Functional genomics
gnomAD constraint: pLI 9.16e-05, LOEUF 0.592, missense Z 3.61 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000452236 — one region, missense o/e 0.80.
Literature-anchored findings (GeneRIF, showing 3)
- the present study indicated that ZNF452 may be an upstream regulator of AKT-GSK3beta signaling pathway and facilitates proliferation and invasion of non-small cell lung cancer (PMID:28418919)
- Genome-wide association study on blood pressure traits in the Iranian population suggests ZBED9 as a new locus for hypertension. (PMID:34083597)
- The AGT epistasis pattern proposed a novel role for ZBED9 in regulating blood pressure: Tehran Cardiometabolic genetic study (TCGS). (PMID:35577038)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zbed5 | ENSMUSG00000034173 |
| rattus_norvegicus | Zbed5 | ENSRNOG00000000918 |
Paralogs (18): GTF2IRD1 (ENSG00000006704), ZMYM2 (ENSG00000121741), ZMYM5 (ENSG00000132950), THAP12 (ENSG00000137492), ZMYM4 (ENSG00000146463), ZMYM3 (ENSG00000147130), ZMYM6 (ENSG00000163867), KIAA1958 (ENSG00000165185), GTF2IRD2B (ENSG00000174428), EPM2AIP1 (ENSG00000178567), GTF2IRD2 (ENSG00000196275), ZMYM1 (ENSG00000197056), QRICH1 (ENSG00000198218), FAM200C (ENSG00000221886), FAM200A (ENSG00000221909), ZBED5 (ENSG00000236287), FAM200B (ENSG00000237765), GTF2I (ENSG00000263001)
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Gorilla gorilla gorilla | A1YEW3 | 100.0% | Diamond |
| Pan paniscus | A1YG26 | 100.0% | Diamond |
| Pan troglodytes | A2T715 | 100.0% | Diamond |
| Pongo abelii | Q5RAE6 | 100.0% | Diamond |
| Pongo pygmaeus | A2T812 | 98.7% | Diamond |
| Macaca nemestrina | A2T6E3 | 98.3% | Diamond |
| Canis lupus familiaris | A4Z944 | 98.3% | Diamond |
| Bos taurus | A4Z943 | 97.4% | Diamond |
| Macaca fascicularis | Q4R6P1 | 96.5% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| TRQ-TTG2-1 | tRNA | 100189138 |
| TRS-GCT4-1 | tRNA | 100189225 |
| TRI-TAT3-1 | tRNA | 100189348 |
| ZBED9-AS1 | ncRNA | 121676925 |
| GPX5 | protein-coding | 2880 |
| TRR-TCG5-1 | tRNA | 100189034 |
| TRA-AGC3-1 | tRNA | 100189299 |
| GPX6 | protein-coding | 257202 |
| TRA-TGC2-1 | tRNA | 100189114 |
| TRT-CGT3-1 | tRNA | 100189360 |
Protein
Protein identifiers
SCAN domain-containing protein 3 — Q6R2W3 (reviewed: Q6R2W3)
Alternative names: Transposon-derived Buster4 transposase-like protein, Zinc finger BED domain-containing protein 9
All UniProt accessions (3): A0A1U9X8W9, A0A2R8Y5N3, Q6R2W3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Tissue specificity. Weakly expressed in the lung (at protein level).
Miscellaneous. Highly expressed in non-small-cell lung carcinoma (NSCLC) tissue, with increased expression correlating with advanced disease, lymph node metastases and poor prognosis, as such may be a candidate prognostic marker. May act as an oncogene and promote tumor growth via positive regulation of cell cycle progression at G1/S phase transition. May promote invasion and metastasis via activation of the AKT/GSK-3 beta signaling pathway. Expressed in the cytoplasm in NSCLC tissue. May be derived from an ancient transposon that has lost its ability to translocate.
RefSeq proteins (2): NP_001316545, NP_443155* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001584 | Integrase_cat-core | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR012337 | RNaseH-like_sf | Homologous_superfamily |
| IPR036397 | RNaseH_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
| IPR057560 | Znf_SCAND3 | Domain |
Pfam: PF02023, PF23663, PF27046, PF27073
UniProt features (13 total): sequence conflict 6, domain 2, coiled-coil region 2, sequence variant 2, chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6R2W3-F1 | 72.39 | 0.28 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nucleoli; golgi apparatus; nucleoplasm
Antibody reliability (HPA): IH uncertain · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 55 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GOBP_DNA_INTEGRATION, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, MODULE_205, KOYAMA_SEMA3B_TARGETS_UP, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_EPITHELIAL_CELL_PROLIFERATION, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE, GOBP_DNA_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION, HMG20B_TARGET_GENES, HOXA7_TARGET_GENES, KLF14_TARGET_GENES, PGBD5_TARGET_GENES, SKIL_TARGET_GENES
GO Biological Process (3): DNA integration (GO:0015074), positive regulation of cell cycle (GO:0045787), positive regulation of epithelial cell proliferation (GO:0050679)
GO Molecular Function (2): nucleic acid binding (GO:0003676), protein dimerization activity (GO:0046983)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
12 GO namespaces:
| Category | Terms |
|---|---|
| DNA metabolic process | 1 |
| cell cycle | 1 |
| positive regulation of cellular process | 1 |
| regulation of cell cycle | 1 |
| positive regulation of cell population proliferation | 1 |
| epithelial cell proliferation | 1 |
| regulation of epithelial cell proliferation | 1 |
| binding | 1 |
| protein binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 7 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| positive regulation of cell cycle | BP | mutant phenotype |
| positive regulation of epithelial cell proliferation | BP | mutant phenotype |
| cytoplasm | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 494 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCAND3 | TSGA10IP | Q3SY00 | 548 |
| SCAND3 | XKR5 | Q6UX68 | 536 |
| SCAND3 | SPDYE5 | A6NIY4 | 430 |
| SCAND3 | ZBED4 | O75132 | 426 |
| SCAND3 | DMBX1 | Q8NFW5 | 381 |
| SCAND3 | TRIM69 | Q86WT6 | 370 |
| SCAND3 | ANGPTL7 | O43827 | 366 |
| SCAND3 | EXOC3L4 | Q17RC7 | 365 |
| SCAND3 | SGIP1 | Q9BQI5 | 357 |
| SCAND3 | ZNF280A | P59817 | 350 |
| SCAND3 | ZBED1 | O96006 | 345 |
| SCAND3 | GIN1 | Q9NXP7 | 345 |
| SCAND3 | GPR31 | O00270 | 344 |
| SCAND3 | SLC5A9 | Q2M3M2 | 341 |
| SCAND3 | VSIG8 | P0DPA2 | 340 |
IntAct
Human interaction partners of SCAND3 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
2 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| KPNA4 | physical association | 0.400 | 1 |
| KRBA2 | physical association | 0.400 | 1 |
Disease & clinical
Genetic variants
Variant evidence for SCAND3: 84 ClinVar records (0 pathogenic / likely pathogenic); 30 GWAS associations.
ClinVar
84 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 3 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 28 predictions of 203):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 6:28579420–28579421 | acceptor_loss | 1.0000 | 6 |
| 6:28579270–28579271 | donor_loss | 0.9900 | 6 |
| 6:28579277 | donor_gain | 0.9900 | |
| 6:28586296–28586297 | donor_loss | 0.9900 | 5 |
| 6:28573828–28573829 | acceptor_loss | 0.9800 | 4 |
| 6:28573834 | acceptor_gain | 0.9800 | |
| 6:28579422 | acceptor_loss | 0.9800 | |
| 6:28586296 | donor_loss | 0.9800 | |
| 6:28573828–28573829 | acceptor_loss | 0.9700 | 2 |
| 6:28581859 | donor_gain | 0.9700 |
AlphaMissense
1,931 missense substitutions predicted likely pathogenic (of 8,798 scored), across 556 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M326 | 9 | 0.888 | 0.970 |
| H315 | 8 | 0.942 | 0.982 |
| F746 | 8 | 0.933 | 0.995 |
| F308 | 8 | 0.929 | 0.994 |
| H779 | 8 | 0.895 | 0.972 |
| F244 | 8 | 0.883 | 0.982 |
| N336 | 8 | 0.868 | 0.973 |
| H320 | 8 | 0.864 | 0.959 |
| H784 | 8 | 0.861 | 0.953 |
| H1325 | 8 | 0.816 | 0.927 |
| D423 | 8 | 0.790 | 0.896 |
| F276 | 7 | 0.965 | 0.994 |
| C349 | 7 | 0.963 | 0.981 |
| F226 | 7 | 0.955 | 0.992 |
| C762 | 7 | 0.941 | 0.982 |
| C352 | 7 | 0.940 | 0.963 |
| C852 | 7 | 0.939 | 0.996 |
| W80 | 7 | 0.934 | 0.982 |
| F795 | 7 | 0.934 | 0.972 |
| E841 | 7 | 0.934 | 0.982 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 0.000124 |
Disease associations
OMIM: gene MIM:615254 | disease phenotypes:
GWAS associations
30 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90016674_3 | Liver iron content | 1e-89 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 2e-27 |
| GCST004521_263 | Autism spectrum disorder or schizophrenia | 3e-26 |
| GCST010241_27 | Apolipoprotein A1 levels | 9e-25 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 4e-24 |
| GCST004521_216 | Autism spectrum disorder or schizophrenia | 1e-19 |
| GCST010083_324 | Hemoglobin levels | 1e-17 |
| GCST010703_224 | Brain morphology (MOSTest) | 7e-16 |
| GCST004521_158 | Autism spectrum disorder or schizophrenia | 2e-15 |
| GCST004521_88 | Autism spectrum disorder or schizophrenia | 5e-14 |
| GCST007326_87 | Number of sexual partners | 2e-13 |
| GCST010988_324 | Adult body size | 2e-13 |
| GCST004748_95 | Lung cancer | 1e-12 |
| GCST012355_12 | Depression | 2e-12 |
| GCST90020028_680 | Hip circumference adjusted for BMI | 2e-12 |
| GCST010142_7 | Fish- and plant-related diet | 3e-12 |
| GCST004750_18 | Squamous cell lung carcinoma | 1e-11 |
| GCST008921_4 | Asthma and major depressive disorder | 2e-11 |
| GCST010702_125 | Subcortical volume (MOSTest) | 3e-11 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 8e-11 |
| GCST010142_16 | Fish- and plant-related diet | 2e-10 |
| GCST006291_39 | Spherical equivalent or myopia (age of diagnosis) | 3e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4e-10 |
| GCST004749_15 | Lung cancer in ever smokers | 7e-9 |
| GCST010142_34 | Fish- and plant-related diet | 7e-9 |
| GCST010142_35 | Fish- and plant-related diet | 8e-9 |
| GCST010142_42 | Fish- and plant-related diet | 1e-8 |
| GCST004749_16 | Lung cancer in ever smokers | 3e-8 |
| GCST003518_34 | Daytime sleep phenotypes | 2e-7 |
| GCST003901_17 | Cognitive decline (age-related) | 5e-6 |
EFO canonical traits (from GWAS)
7 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
| EFO:0004847 | age at onset |
| EFO:0004509 | hemoglobin measurement |
| EFO:0008111 | diet measurement |
| EFO:0004614 | apolipoprotein A 1 measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| potassium chromate(VI) | decreases expression, affects cotreatment, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| bisphenol F | affects cotreatment, decreases methylation | 1 |
| urushiol | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | increases expression | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| monobutyl phthalate | increases methylation, increases abundance | 1 |
| ferrous chloride | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| avobenzone | decreases expression | 1 |
| chromium hexavalent ion | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phthalic Acids | increases abundance, increases methylation | 1 |
| Quercetin | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): lung carcinoma, refractive error, squamous cell lung carcinoma